Stock search

Ticker or company name

Compare stocks

Market: US

  • CVSCVS Health
  • SYKStryker Corporation
  • HCAHCA Healthcare

Add stock

Ticker or company

Summary

CVS
CVS Health
$88,59Down −0,85%
Year: Up +13%
83/100Best scoreRatio would consider buying
Open stock page
SYK
Stryker Corporation
$310,72Up +0,35%
Year: Down −17%
72/100Ratio would consider buying
Open stock page
HCA
HCA Healthcare
$511,78Up +2,55%
Year: Up +5%
69/100Ratio would watch
Open stock page

Verdict

CVS has the best score (83). SYK grows revenue the fastest. CVS is the cheapest by forward P/E. CVS has the lowest debt load. SYK has the highest net margin.

Verdict by our methodology based on current metrics. Not an investment recommendation.

Traffic light — 10 checks

CheckCVS6 ✓ 3 — 0 ✕SYK5 ✓ 3 — 1 ✕HCA4 ✓ 3 — 1 ✕
P/E vs its history10,433,015,4
P/E vs industry10,433,015,4
Forward P/E10,718,215,2
Revenue growth, YoY+6,7%+7,9%+5,8%
EPS growth, YoY+2 107,7%+23,4%+16,5%
Net margin2,6%13,8%8,6%
Net debt / EBITDA−0,81,8n/a—
Free cash flow$15,6 bn$4,57 bn$5,97 bn
Share count over a year+1,7%−0,5%−8,0%
Cash runwayn/anot neededn/anot neededn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterCVSTTMSYKTTMHCATTMIndustry medianTTM
P/E TTM ↓Best: 10,4Worst: 33,015,425,1
Forward P/E ↓Best: 10,7Worst: 18,215,216,2
PEG ↓Best: 1,8Worst: 3,11,82,2
P/S TTM ↓Best: 0,3Worst: 4,51,32,2
EV/EBITDA ↓10,8Worst: 21,5Best: 9,717,3
P/FCF ↓Best: 7,3Worst: 26,117,519,5

Price, %

  • CVSn/a
  • SYKn/a
  • HCAn/a

Returns

Best WorstNo mark — in between

PeriodCVSSYKHCA
1 yearn/an/an/a
3 yearsn/an/an/a
5 yearsn/an/an/a
All timen/an/an/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

CVSSYKHCA
Share of “buy”Best: 88%77%Worst: 58%
Beat the forecastBest: 4 of 4Worst: 2 of 43 of 4
Average “surprise”Best: +22,0%Worst: −2,5%+4,1%
Insiders over 12 monthssales $322 msales $580 msales $47,5 m

Details are on each stock page.